Tzannes Sophia, Hammond Margaret F, Murphy Suzanne, Sparkes Andrew, Blackwood Laura
Department of Veterinary Clinical Science, University of Liverpool, Leahurst, Neston, CH64 7TE, UK.
J Feline Med Surg. 2008 Feb;10(1):73-81. doi: 10.1016/j.jfms.2007.05.008. Epub 2007 Sep 12.
Questionnaires regarding the perceptions of chemotherapy and its impact on the quality of life (QoL) of their cat were received from owners of 31 cats treated for lymphoma between 2002 and 2006 with COP (cyclophosphamide, vincristine, prednisolone) chemotherapy. The QoL scores prior to the onset of cancer (mean 9.5, range 6-10) were significantly higher than the ratings given after the onset of cancer but before commencement of chemotherapy (mean 3.9, range 1-9.4). The QoL scores during chemotherapy (mean 6.3, range 1-10) were also significantly lower than prior to the onset of cancer, but significantly higher during treatment than prior to starting treatment. Adverse effects were experienced by 27 (87%) cats during the course of chemotherapy. Twenty-five (83%) of clients were happy they treated their cat and 27 owners (87%) would treat another cat. The results suggest that COP chemotherapy is perceived by owners to be tolerated by cats.
我们收到了2002年至2006年间接受COP(环磷酰胺、长春新碱、泼尼松龙)化疗治疗淋巴瘤的31只猫的主人填写的关于化疗认知及其对猫生活质量(QoL)影响的问卷。癌症发病前的生活质量评分(平均9.5,范围6 - 10)显著高于癌症发病后但化疗开始前的评分(平均3.9,范围1 - 9.4)。化疗期间的生活质量评分(平均6.3,范围1 - 10)也显著低于癌症发病前,但治疗期间显著高于开始治疗前。27只(87%)猫在化疗过程中出现了不良反应。25位(83%)主人对治疗他们的猫感到满意,27位主人(87%)会治疗另一只猫。结果表明,主人认为COP化疗猫是可以耐受的。